← Leaderboards
Benny Abraham Kaipparettu
Baylor College Of Medicine
$6,184,479
Attributed
$6,593,590
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $950.6K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,593,590 · 10
By mechanism
R01$4,891,968 · 3
R21$991,842 · 2
R03$633,500 · 4
P20$76,280 · 1
Top collaborators
- Junhyoung Park2 shared
- Ashok Kumar1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Suzanne A Fuqua$14,426,929
- Bert W O'Malley$52,747,816
- Dean P Edwards$14,755,448
- K. Vinod Vijayan$5,758,058
- Junhyoung Park$80,000
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsNeoplasm MetastasisMalignant Breast NeoplasmRegulationPathway InteractionsNuclearMitochondriaTriple-Negative Invasive Breast CarcinomaMetabolomicsBioinformaticsProteinsCellsSrc GeneIn VivoIn VitroBenignDrug TargetingMediatingTumor ProgressionBreast Cancer PatientBreast Cancer CellReportingFatty Acids
Grant awards (30)
TAK1 signaling in Rhabdomyosarcoma tumorigenesis and growth$658,223
R01 · FY2025 · CA
RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER$347,701
R01 · FY2024 · CA · contact PI
Disabled-2 in the metabolic regulation of oncopathways$80,000
R03 · FY2024 · CA · contact PI
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors$36,264
P20 · FY2024 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$408,517
R01 · FY2023 · CA · contact PI
RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER$358,680
R01 · FY2023 · CA · contact PI
Disabled-2 in the metabolic regulation of oncopathways$80,000
R03 · FY2023 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$63,342
R01 · FY2023 · CA · contact PI
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors$40,016
P20 · FY2023 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$408,517
R01 · FY2022 · CA · contact PI
RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER$358,680
R01 · FY2022 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$117,994
R01 · FY2022 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$534,690
R01 · FY2021 · CA · contact PI
RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER$367,474
R01 · FY2021 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$414,287
R01 · FY2020 · CA · contact PI
RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER$381,240
R01 · FY2020 · CA · contact PI
High-fat diet-mediated activation of Src oncopathway in triple negative breast cancer$79,250
R03 · FY2020 · CA · contact PI
ENERGY REPROGRAMMING-REGULATED ONCOPATHWAYS AND DRUG RESISTANCE IN TRIPLE NEGATIVE BREAST CANCER$55,768
R01 · FY2020 · CA · contact PI
Energy reprogramming-regulated oncopathways and drug resistance in triple negative breast cancer$416,855
R01 · FY2019 · CA · contact PI
High-fat diet-mediated activation of Src oncopathway in triple negative breast cancer$79,250
R03 · FY2019 · CA · contact PI
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer$79,250
R03 · FY2018 · CA · contact PI
Mitochondrial DNA copy number and fat metabolism in triple negative breast cancer$79,250
R03 · FY2017 · CA · contact PI
Mitochondria-nuclear crosstalk in triple negative breast cancer racial disparity$199,986
R21 · FY2015 · CA · contact PI
Mitochondria-nuclear crosstalk in triple negative breast cancer racial disparity$53,212
R21 · FY2015 · CA · contact PI
Mitochondria specific metabolomic signature in triple negative breast cancer meta$165,089
R21 · FY2014 · CA · contact PI
Mitochondria-nuclear crosstalk in triple negative breast cancer racial disparity$165,089
R21 · FY2014 · CA · contact PI
Mitochondria-nuclear crosstalk in triple negative breast cancer racial disparity$204,233
R21 · FY2013 · CA · contact PI
Mitochondria specific metabolomic signature in triple negative breast cancer meta$204,233
R21 · FY2013 · CA · contact PI
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status$78,250
R03 · FY2012 · CA · contact PI
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status$78,250
R03 · FY2011 · CA · contact PI